IF0.DE
Price:
$2.939
Market Cap:
$61.25M
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune dis...[Read more]
Industry
Biotechnology
IPO Date
2019-12-02
Stock Exchange
XETRA
Ticker
IF0.DE
According to InflaRx N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 48.84M. This represents a change of -13.00% compared to the average of 56.14M of the last 4 quarters.
The mean historical Enterprise Value of InflaRx N.V. over the last ten years is 231.37M. The current 48.84M Enterprise Value has changed 2.01% with respect to the historical average. Over the past ten years (40 quarters), IF0.DE's Enterprise Value was at its highest in in the March 2019 quarter at 816.62M. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.
Average
231.37M
Median
136.20M
Minimum
59.54M
Maximum
740.49M
Discovering the peaks and valleys of InflaRx N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.04%
Maximum Annual Enterprise Value = 740.49M
Minimum Annual Increase = -91.96%
Minimum Annual Enterprise Value = 59.54M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 122.97M | 77.26% |
| 2023 | 69.37M | -38.65% |
| 2022 | 113.08M | -24.33% |
| 2021 | 149.44M | 73.82% |
| 2020 | 85.98M | 44.40% |
| 2019 | 59.54M | -91.96% |
| 2018 | 740.49M | 170.04% |
| 2017 | 274.22M | -23.36% |
| 2016 | 357.79M | 4.99% |
The current Enterprise Value of InflaRx N.V. (IF0.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
101.80M
5-year avg
108.17M
10-year avg
231.37M
InflaRx N.V.’s Enterprise Value is less than 4SC AG (145.48M), less than Haemato AG (93.05M), less than Inovio Pharmaceuticals, Inc. (113.31M), less than Clovis Oncology, Inc. (494.94M), greater than Core One Labs Inc. (6.48M), greater than CytoTools AG (-441171.00), greater than co.don AG (6.25M), greater than Medigene AG (-3756530.00), greater than ViewRay, Inc. (-44998227.00), less than Aurora Cannabis Inc. (386.24M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 145.48M | $150.70M | |
| 93.05M | $111.50M | |
| 113.31M | $12.56M | |
| 494.94M | $13.19M | |
| 6.48M | $4.55M | |
| -441171.00 | $164.40K | |
| 6.25M | $6.55M | |
| -3756530.00 | $1.97M | |
| -44998227.00 | $207.23M | |
| 386.24M | $19.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InflaRx N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like InflaRx N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is InflaRx N.V.'s Enterprise Value?
What is the highest Enterprise Value for InflaRx N.V. (IF0.DE)?
What is the 3-year average Enterprise Value for InflaRx N.V. (IF0.DE)?
What is the 5-year average Enterprise Value for InflaRx N.V. (IF0.DE)?
How does the current Enterprise Value for InflaRx N.V. (IF0.DE) compare to its historical average?